Should I use beta-blockers as a first-line treatment for hypertension?
Most of the evidence for these conclusions comes from trials of atenolol (75% of beta-blocker participants in this review). However, it is not known at present whether beta-blockers have differential effects on younger and elderly patients or whether there are differences between the different sub-types of beta-blockers.
Hypertension is a key risk factor for stroke and myocardial infarction. Cardiovascular disease is the leading cause of death in developing countries accounting for about 40% of all deaths.